These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7093934)

  • 1. Conditions for the generation of high serum levels of C3DP.
    White PJ; Hoch SO
    Cancer Biochem Biophys; 1982; 6(1):19-22. PubMed ID: 7093934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical evaluation of serum C3DP levels in individuals with malignant diseases.
    Parsons RG; Longmire RL; Hoch SO; Hoch JA
    Cancer Res; 1977 Mar; 37(3):692-5. PubMed ID: 837370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A correlation of serum C3DP levels with chemotherapeutic management of cancer patients.
    Parsons RG; Hoch JA; Longmire RL
    Cancer; 1978 Jun; 41(6):2099-106. PubMed ID: 657083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy-associated DNA-binding protein C3DP from human serum. Further characterization and purification of C3DP retaining its DNA-binding affinity.
    Schröder C; Weinblum D; Zahn RK; Dose K
    Hoppe Seylers Z Physiol Chem; 1979 Mar; 360(3):473-6. PubMed ID: 437697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equilibrium binding constants of C3DP, a nucleic acid-binding protein isolated from human serum.
    Schröder C; Weinblum D
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1599-607. PubMed ID: 6172355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a human serum DNA-binding protein associated with malignant disease.
    Parsons RG; Aldenderfer PH; Kowal R
    J Natl Cancer Inst; 1979 Jul; 63(1):43-7. PubMed ID: 221718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of a serum DNA-binding protein (64DP) in the diagnosis of malignant neoplasms.
    Mitomi T; Nakasaki H; Tajima T; Ogoshi K; Tsuda M; Katsunuma T
    Int Adv Surg Oncol; 1982; 5():245-59. PubMed ID: 6807849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI; McLeod E; Devine DV
    J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
    Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
    Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of blood levels of soluble 53 kDa protein and CEA in monitoring colon cancer patients.
    Sandler B; Smirnoff P; Shani A; Idelevich E; Kaganski N; Pfefferman R; Davidovich B; Zusman I
    Anticancer Res; 1999; 19(5B):4229-33. PubMed ID: 10628379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [False results on elevated triiodothyronine values in radioimmunoassay].
    Skovsted L; Hansen JE; Nygaard B
    Ugeskr Laeger; 1995 Oct; 157(41):5725-7. PubMed ID: 7571111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum modulation of neutrophil response to Porphyromonas gingivalis LPS in periodontal disease.
    Soolari AS; Champagne C; Punzi JS; Amar S; Van Dyke TE
    J Int Acad Periodontol; 1999 Oct; 1(4):101-9. PubMed ID: 12666954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV-16-related proteins as the serologic markers in cervical neoplasia.
    Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
    Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma.
    Bergenheim AT; Björk P; Bergh J; von Schoultz E; Svedberg H; Henriksson R
    Cancer Res; 1994 Sep; 54(18):4974-9. PubMed ID: 8069865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stability of serum hepatitis C viral RNA in various handling and storage conditions.
    Fong TL; Charboneau F; Valinluck B; Govindarajan S
    Arch Pathol Lab Med; 1993 Feb; 117(2):150-1. PubMed ID: 8381268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modification of complement components under the effect of cationic proteins from leukocytes from donors and leukemia patients].
    Rybakova LP; Tiagotin IuV; Goncharova SV; Kulikova IN; Trofimov AV
    Vopr Med Khim; 1993; 39(5):38-41. PubMed ID: 8279141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of IGFBP properties in toad and rat sera.
    Cortizo AM; Braziunas D; Jasper H; Gagliardino JJ
    Gen Comp Endocrinol; 1993 Nov; 92(2):242-9. PubMed ID: 7506683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
    Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
    Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
    Weightman DR; Mallick UK; Fenwick JD; Perros P
    Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.